Search

everythinglearnresearchcommunity

for

Search:↓

Menopause can cause skin issues, and seeing a dermatologist helps.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

New treatments for hair loss are being developed using molecular biology.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Apremilast shows promise for several skin conditions but needs more research.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Stabilizing HIF-1A in hair follicles may reduce oxidative stress and promote hair growth by increasing glycolysis.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Mutations in the P2RY5 gene cause hereditary woolly hair.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Growing human skin cells in a 3D environment can stimulate new hair growth.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.